Concepedia

Louis Plüss

LP

Statistics

Publications

4

Citations

50

H-Index

4

Active since

2018

Affiliations

ETH Zurich(Current)

Philochem (Switzerland)

Philogen (Italy)

Louis Plüss is an author at ETH Zurich specializing in antibody-dependent cell-mediated cytotoxicity, monoclonal antibodies in cancer, and oncology.

ORCID

Publications per year

2018–2023

4

Publications

4

A novel human monoclonal antibody specific to the A33 glycoprotein recognizes colorectal cancer and inhibits metastasis

Patrizia Murer, Louis Plüss, Dario Neri · mAbs · 2020 · 15 citations · Full text

, , +17

Targeted Delivery of TNF Potentiates the Antibody-Dependent Cell-Mediated Cytotoxicity of an Anti-Melanoma Immunoglobulin

Patrizia Murer, Jonathan D. Kiefer, Louis Plüss et al. · Journal of Investigative Dermatology · 2018 · 13 citations · Full text

, , +15

Generation and <i>in vivo</i> characterization of a novel high-affinity human antibody targeting carcinoembryonic antigen

Louis Plüss, Frederik Peissert, Abdullah Elsayed et al. · mAbs · 2023 · 12 citations · Full text

, , +17

Selection of a <scp>PD</scp>‐1 blocking antibody from a novel fully human phage display library

Frederik Peissert, Louis Plüss, Anna Maria Giudice et al. · Protein Science · 2022 · 10 citations · Full text

, , +17

1–4 of 4